Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

2-(1-(hydroxycarbamoyl)-4-phenyl-3-butenyl)-2'-isobutyl-2'-(methanesulfonyl)-4-methylvalerohydrazide MeSH Supplementary Concept Data 2025


MeSH Supplementary
2-(1-(hydroxycarbamoyl)-4-phenyl-3-butenyl)-2'-isobutyl-2'-(methanesulfonyl)-4-methylvalerohydrazide
Unique ID
C459386
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C459386
Entry Term(s)
Ro 32-7315
Ro-32-7315
Registry Numbers
0
Heading Mapped to
*Hydroxamic Acids
*Sulfonamides
Frequency
4
Note
inhibits tumor necrosis factor-alpha convertase; structure in first source
Source
J Pharmacol Exp Ther 2002 Jul;302(1):390-6
Date of Entry
2002/07/09
Revision Date
2004/02/02
2-(1-(hydroxycarbamoyl)-4-phenyl-3-butenyl)-2'-isobutyl-2'-(methanesulfonyl)-4-methylvalerohydrazide Preferred
Ro 32-7315 Narrower
page delivered in 0.004s